🔗 Permalink

Inventor profile of:

Marc Ferrer

City:

Potomac, Maryland

Country:

United States

Published Applications:

18

Last publication date:

2025-05-01

Top Assignees for applications by Marc Ferrer

The entities that hold a legal rights for patent applications filed by inventor Ferrer Marc:

The United States of America,as represented by the Secretary,Department of Health and Human Services 5 Bethesda, MD United States
UNIVERSITY OF KANSAS 5 Lawrence, KS United States
Northwestern University 3 Evanston, IL United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 2 Washington, DC United States
The United States of Americans represented by the Secretary, Department of Health and Human Services 2 Bethesda, MD United States
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE 2 Santiago, Chile
The USA, as represented by the Secretary, Dept. of Health and Human Services 2 Bethesda, MD United States
THE JOHNS HOPKINS UNIVERSITY 2 Baltimore, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 2 Bethesda, MD United States
THE UNITED STATES OF AMERICA, as represented by th 1 Washington, DC United States
Pontifica Universidad Catoclica de Chile 1 Santiago, Chile
The University of North Carolina at Chapel Hill 1 Chapel Hill, NC United States
THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 1 Miami, FL United States
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services 1 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Serv 1 Bethesda, MD United States
The Regents of the University of Colorado, a body corporate 1 Denver, CO United States
Department of Health and Human Services 1 Rockville, MD United States
The United States of America, As Represented by the Secretary, Department of Health & Human Services 1 Bethesda, MD United States

Recent patent applications by Ferrer Marc

Marc Ferrer from Potomac, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-01

US20250134907A1

Human necessities

FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF

#2 | 2024-09-26

US20240316056A1

Human necessities

FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS

#3 | 2024-05-02

US20240141291A1

Chemistry; metallurgy

FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE

#4 | 2023-09-28

US20230303501A1

Chemistry; metallurgy

C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME

#5 | 2023-01-05

US20230000857A1

Human necessities

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

#6 | 2022-10-06

US20220315548A1

Chemistry; metallurgy

SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF

#7 | 2021-06-24

US20210186972A1

Human necessities

FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS

#8 | 2021-04-08

US20210101872A1

Chemistry; metallurgy

C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

#9 | 2021-02-11

US20210040074A1

Chemistry; metallurgy

POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF

#10 | 2021-01-07

US20210000798A1

Human necessities

2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1H-imidazol-2-yl)-phenol (DPTIP) a small molecule inhibitor of neutral sphingomyelinase 2 (nSMase-2) for the treatment of neurodegenerative and oncologic diseases

#11 | 2020-11-26

US20200369649A1

Chemistry; metallurgy

Autophagy modulators for use in treating cancer

#12 | 2020-05-28

US20200165257A1

Chemistry; metallurgy

INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE AND HISTONE DEACETYLASE FOR TREATMENT OF CANCER

#13 | 2020-01-09

US20200009146A1

Human necessities

Autophagy inducers for treatment of CNS conditions

#14 | 2019-01-24

US20190022083A1

Human necessities

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

#15 | 2017-04-27

US20170114053A1

Chemistry; metallurgy

Heterocyclic compounds and methods of use thereof

#16 | 2017-01-05

US20170001988A1

Chemistry; metallurgy

PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER

#17 | 2016-06-23

US20160176831A1

Chemistry; metallurgy

11-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonists

#18 | 2014-06-05

US20140155420A1

Human necessities

INHIBITORS OF EYA2

InventorID:

787986 ⎘